SHELL ASSET MANAGEMENT CO - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 198 filers reported holding HERON THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 2.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
SHELL ASSET MANAGEMENT CO ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$180,000
+42.9%
8,5230.0%0.00%
+33.3%
Q3 2020$126,000
+0.8%
8,5230.0%0.00%0.0%
Q2 2020$125,000
+23.8%
8,523
-0.8%
0.00%0.0%
Q1 2020$101,000
-50.7%
8,593
-1.5%
0.00%
-25.0%
Q4 2019$205,000
+23.5%
8,725
-2.9%
0.00%0.0%
Q3 2019$166,000
-1.8%
8,987
-0.8%
0.00%0.0%
Q2 2019$169,000
-25.6%
9,064
-2.2%
0.00%
-20.0%
Q1 2019$227,000
-5.4%
9,2710.0%0.01%
-16.7%
Q4 2018$240,000
-24.8%
9,271
-7.9%
0.01%0.0%
Q3 2018$319,00010,0710.01%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
TANG KEVIN C 21,288$250,00019.87%
TANG CAPITAL MANAGEMENT LLC 2,896,904$34,010,0004.78%
PFM Health Sciences, LP 2,481,917$29,138,0002.39%
Iron Triangle Partners LP 500,000$5,870,0002.27%
NEXPOINT ASSET MANAGEMENT, L.P. 777,599$9,129,0001.72%
Pekin Hardy Strauss, Inc. 588,732$6,912,0001.55%
First Light Asset Management, LLC 691,400$8,117,0001.39%
Congress Park Capital LLC 111,045$1,304,0001.18%
Mesirow Financial Investment Management, Inc. 15,135$178,0001.12%
Elk Creek Partners, LLC 509,174$5,978,0001.03%
View complete list of HERON THERAPEUTICS INC shareholders